Literature DB >> 21561895

Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis.

Joanna Natorska1, Ksenia Bykowska, Marta Hlawaty, Grzegorz Marek, Jerzy Sadowski, Anetta Undas.   

Abstract

BACKGROUND: High molecular weight von Willebrand factor (vWF) multimers (HMWM) are often deficient in patients with severe aortic stenosis (AS) owing to shear stress-enhanced proteolysis of vWF. It has also been reported that AS is associated with increased activation of blood coagulation.
OBJECTIVE: To investigate whether patients with AS with a deficiency in vWF HMWM have enhanced thrombin generation and platelet activation in vivo.
DESIGN: Based on the analysis of vWF HMWM performed using immunolocalisation, 11 subjects with vWF HMWM deficiency (low %HMWM group) were identified and compared with 42 patients with AS with a normal distribution of vWF HMWM (normal %HMWM group). Plasma thrombin markers thrombin-antithrombin complexes (TAT) and prothrombin factor 1+2 (F1.2) plus platelet activation markers soluble CD40 ligand (sCD40L), β-thromboglobulin and P-selectin were also measured. PATIENTS: 48 consecutive patients with severe AS and five with moderate AS, free of angiographically-proven coronary artery disease and clinically overt bleeding, were studied.
RESULTS: Patients in the low %HMWM group had 34.8% higher maximal transvalvular gradient (p = 0.0003) and 44.8% higher mean gradient (p = 0.0002) than those in the normal %HMWM group. Thrombin formation was enhanced in the low %HMWM group (F1.2, 284.5 ± 63.7 vs 216.9 ± 62.5 pmol/l, p = 0.004; thrombin-antithrombin, 4.89 ± 1.3 vs 4.06 ± 0.9 μg/l, p = 0.02) and both markers showed inverse correlations with the percentage of vWF HMWM (r = -0.59, p = 0.002; r = -0.42, p = 0.03, respectively). In the low %HMWM group sCD40L (279.4 ± 60.7 vs 221.4 ± 41.7 pmol/l, p = 0.003) and β-thromboglobulin (73.1 ± 9.2 vs 64.5 ± 8.5 IU/ml, p = 0.04), but not P-selectin, were also higher than in the remaining patients with AS.
CONCLUSION: Patients with advanced AS deficient in vWF HMWM are characterised by enhanced thrombin formation and platelet activation. This observation indicates the ambivalent impact of high shear stress in AS on haemostasis and might help explain two aspects of AS-Heyde syndrome and increased risk of thromboembolism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21561895     DOI: 10.1136/hrt.2010.217273

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  12 in total

1.  Activated platelets promote an osteogenic programme and the progression of calcific aortic valve stenosis.

Authors:  Rihab Bouchareb; Marie-Chloé Boulanger; Lionel Tastet; Ghada Mkannez; Mohamed J Nsaibia; Fayez Hadji; Abdellaziz Dahou; Younes Messadeq; Benoit J Arsenault; Philippe Pibarot; Yohan Bossé; André Marette; Patrick Mathieu
Journal:  Eur Heart J       Date:  2019-05-01       Impact factor: 29.983

2.  Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS).

Authors:  Joanna Rupa-Matysek; Krzysztof Lewandowski; Maria Lewandowska; Ewelina Wojtasińska; Marzena Liliana Wojtaszewska; Michał Walczak; Ksenia Bykowska; Mieczysław Komarnicki
Journal:  Int J Hematol       Date:  2014-11-29       Impact factor: 2.490

3.  Changes in platelet indices in children with bicuspid aortic valve.

Authors:  Aylin Canbolat Ayhan; Yusuf Izzet Ayhan; Ozlem Kalaycık; Cetin Timur; Asım Yoruk
Journal:  Pediatr Cardiol       Date:  2014-11-21       Impact factor: 1.655

4.  Outcomes associated with dual antiplatelet therapy after myocardial infarction in patients with aortic stenosis.

Authors:  Andreas Martinsson; Xinjun Li; Christian Torp-Pedersen; Bengt Zöller; Pontus Andell; Charlotte Andreasen; Gunnar Gislason; Lars Køber; Kristina Sundquist; J Gustav Smith; Charlotte Andersson
Journal:  Int J Cardiol       Date:  2019-01-19       Impact factor: 4.164

5.  High Density Lipoprotein and it's Dysfunction.

Authors:  Esin Eren; Necat Yilmaz; Ozgur Aydin
Journal:  Open Biochem J       Date:  2012-07-27

6.  Platelet expression of stromal cell-derived factor-1 is associated with the degree of valvular aortic stenosis.

Authors:  Thomas Wurster; Roland Tegtmeyer; Oliver Borst; Dominik Rath; Tobias Geisler; Meinrad Gawaz; Boris Bigalke
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

7.  Platelet-to-Lymphocyte Ratio May Predict the Severity of Calcific Aortic Stenosis.

Authors:  Serkan Akdag; Aytac Akyol; Muntecep Asker; Ramazan Duz; Hasan Ali Gumrukcuoglu
Journal:  Med Sci Monit       Date:  2015-11-06

8.  Can Blood Biomarkers Help Predicting Outcome in Transcatheter Aortic Valve Implantation?

Authors:  Cécile Oury; Alain Nchimi; Patrizio Lancellotti; Jutta Bergler-Klein
Journal:  Front Cardiovasc Med       Date:  2018-03-28

9.  Higher Preoperative Plasma Thrombin Potential in Patients Undergoing Surgery for Aortic Stenosis Compared to Surgery for Stable Coronary Artery Disease.

Authors:  Axel Dimberg; Ulrica Alström; Elisabeth Ståhle; Christina Christersson
Journal:  Clin Appl Thromb Hemost       Date:  2018-05-16       Impact factor: 2.389

10.  Peri-procedural hemostasis disorders in surgical and transcatheter aortic valve implantation.

Authors:  Katarzyna Czerwińska-Jelonkiewicz; Krzysztof Milewski; Piotr Buszman; Przemysław Kwasiborski; Krzysztof Sanetra; Wojciech Domaradzki; Paweł Buszman
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-03-15       Impact factor: 1.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.